| Ind-Swift Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532305 |
NSE Symbol : INDSWFTLAB |
P/E(TTM) : 5.99 |
|
ISIN Demat : INE915B01019 |
Div & Yield% : - |
EPS(TTM) : 18.06 |
|
Book Value(₹) : 170.51 |
Market Cap(₹Cr) : 638.85 |
Face Value(₹) : 10.00 |
| Particulars | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | 1,227.32 | 1,151.96 | 988.09 | 856.58 | 751.84 |
| Excise Duty | - | - | - | - | - |
| Net Sales | 1,227.32 | 1,151.96 | 988.09 | 856.58 | 751.84 |
| Other Income | 431.90 | 33.28 | 42.50 | 23.13 | 36.02 |
| Stock Adjustments | -37.07 | 12.34 | 39.47 | 2.48 | 12.44 |
| Total Income | 1,622.15 | 1,197.58 | 1,070.06 | 882.19 | 800.30 |
| EXPENDITURE : | |||||
| Raw Materials | 586.51 | 629.18 | 537.62 | 427.47 | 391.29 |
| Power and Fuel Cost | 61.43 | 76.07 | 58.40 | 37.31 | 34.65 |
| Other Manufacturing Expenses | 42.34 | 38.53 | 36.51 | 28.76 | 25.73 |
| Selling and Administration Expenses | 77.92 | 63.98 | 62.17 | 78.98 | 69.66 |
| Miscellaneous Expenses | 23.20 | 28.40 | 16.22 | 1.87 | 0.62 |
| Employee Benefit Expenses | 148.88 | 132.70 | 124.62 | 104.17 | 100.38 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 681.87 | 228.73 | 234.52 | 203.63 | 177.98 |
| Interest | 51.10 | 92.17 | 95.55 | 100.22 | 107.48 |
| Gross Profit | 630.77 | 136.56 | 138.97 | 103.41 | 70.50 |
| Depreciation | 53.30 | 57.36 | 130.97 | 87.29 | 90.06 |
| Profit Before Tax | 577.47 | 79.20 | 8.00 | 16.12 | -19.56 |
| Current Tax | 169.92 | 13.36 | 24.62 | 11.04 | 0.41 |
| Fringe Benefit tax | - | - | - | - | - |
| Deferred Tax | -10.84 | 23.36 | -10.92 | 9.48 | 0.82 |
| Reported Net Profit | 418.39 | 42.47 | -5.71 | -4.40 | -20.79 |
| Extraordinary Items | 280.50 | -13.39 | -3.13 | - | 0.07 |
| Adjusted Net Profit | 137.89 | 55.86 | -2.58 | -4.40 | -20.86 |
| Adjustment below Net Profit | - | - | - | - | - |
| Profit/Loss Balance carried down | -37.69 | -80.16 | -74.45 | -70.05 | -49.26 |
| Statutory Appropriations | - | - | - | - | - |
| Appropriations | - | - | - | - | - |
| P & L Balance carried down | 380.70 | -37.69 | -80.16 | -74.45 | -70.05 |
| Dividend | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Equity Dividend (%) | - | - | - | - | - |
| Dividend Per Share(Rs) | - | - | - | - | - |
| Earnings Per Share-Unit Curr | 70.81 | 7.10 | -0.95 | -0.74 | -3.48 |
| Earnings Per Share(Adj)-Unit Curr | 70.81 | 7.10 | -0.95 | -0.74 | -3.48 |
| Book Value | 156.08 | 82.26 | 72.91 | 71.55 | 70.15 |
| Book Value(Adj)-Unit Curr | 156.08 | 82.26 | 72.91 | 71.55 | 70.15 |